Skip to content

Effect of transcranial Direct Current Stimulation (small battery operated devices delivering 2mA of current to specific regions of the brain) on cognitive functions and symptoms of depression in patients suffering from depression

Effect of Prefronto-cerebellar transcranial Direct Current Stimulation (tDCS) on neurocognitive functions and depressive symptomatology in depression: A sham-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019300
Enrollment
70
Registered
2019-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F330- Major depressive disorder, recurrent, mild Health Condition 2: F331- Major depressive disorder, recurrent, moderate Health Condition 3: F320- Major depressive disorder, singleepisode, mild Health Condition 4: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: Active Prefronto-cerebellar transcranial direct current stimulation: Ten sessions of active Prefronto-cerebellar tDCS, twice a day, 2 hours apart, 20 mins each, giving 2 mA of current p

Sponsors

Manipal University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with mild and moderate depression according to ICD 10 criteria 2. Patients who are able to give written informed consent to undergo tDCS 3. Patients of either gender 4. Patients who have been administered a stable dose of antidepressants and/or antipsychotic/mood stabilizers for at least 2 weeks 5. At least five years of formal education (primary level)

Exclusion criteria

Exclusion criteria: 1. Psychiatric co-morbidities, which will be ruled out using the MINI PLUS scale (Excluding Tobacco Dependence Syndrome) 2. Patients not willing to give consent 3. Advanced liver, kidney, cardiac or pulmonary diseases 4. Contraindications to tDCS e.g. metal or medical devices implanted in the body 5. Patients with a history of seizures 6. Patients in remission i.e. patients with a baseline HAM-D score of 7. Patients with Severe Depression 8. Patients with a history Bipolar disorder 9. Patients on Benzodiazepines at the time of tDCS procedure

Design outcomes

Secondary

MeasureTime frame
Reduction in depressive score â?¥50% HAM-D and IDS scores in patients receiving tDCS. Timepoint: 4 weeks

Primary

MeasureTime frame
Change in neurocognitive functions in patients receiving tDCSTimepoint: 4 weeks

Countries

India

Contacts

Public ContactRuthshee Suresh

Kasturba Medical College, Manipal

savithasoman@yahoo.com9845240653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026